Australia - English - Department of Health (Therapeutic Goods Administration)

fair-med healthcare australia pty ltd - famciclovir -

Australia - English - Department of Health (Therapeutic Goods Administration)

fair-med healthcare australia pty ltd - famciclovir -

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - famciclovir, quantity: 250 mg - tablet - excipient ingredients: macrogol 8000; hypromellose; poloxamer; titanium dioxide; stearic acid - famciclovir is indicated for:. - the treatment of herpes zoster infection in adult patients who commence therapy within 72 hours of the onset of rash. greatest benefit occurs if the drug is started within 48 hours. efficacy has not been demonstrated in patients less than 50 years of age, although the occasional younger patient with severe herpes zoster may benefit from therapy with famciclovir. herpes zoster infection is generally a milder condition in younger patients.. - the treatment of recurrent episodes of genital herpes in adults and adolescents 12 years of age and older.. - suppression of recurrent genital herpes.. - the treatment of recurrent herpes labialis (cold sores) in immunocompetent adult patients.. famciclovir is indicated in immunocompromised patients for:. - treatment of uncomplicated herpes zoster;. - treatment of recurrent herpes simplex;. - suppression of recurrent herpes simplex.

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - famciclovir, quantity: 125 mg - tablet - excipient ingredients: titanium dioxide; hypromellose; macrogol 8000; stearic acid; poloxamer - famciclovir is indicated for:. - the treatment of herpes zoster infection in adult patients who commence therapy within 72 hours of the onset of rash. greatest benefit occurs if the drug is started within 48 hours. efficacy has not been demonstrated in patients less than 50 years of age, although the occasional younger patient with severe herpes zoster may benefit from therapy with famciclovir. herpes zoster infection is generally a milder condition in younger patients.. - the treatment of recurrent episodes of genital herpes in adults and adolescents 12 years of age and older.. - suppression of recurrent genital herpes.. - the treatment of recurrent herpes labialis (cold sores) in immunocompetent adult patients.. famciclovir is indicated in immunocompromised patients for:. - treatment of uncomplicated herpes zoster;. - treatment of recurrent herpes simplex;. - suppression of recurrent herpes simplex.

Ireland - English - HPRA (Health Products Regulatory Authority)

medinutrix ltd. - famciclovir - film-coated tablet - 500 milligram(s) - nucleosides and nucleotides excl. reverse transcriptase inhibitors; famciclovir - nucleosides and nucleotides excluding reverse transcriptase inhibitors - famciclovir is indicated for - the treatment of herpes zoster and ophthalmic zoster in immunocompetent adults - the treatment of herpes zoster in immunocompromised adults - the treatment of first and recurrent episodes of genital herpes in immunocompetent adults - the treatment of recurrent episodes of genital herpes in immunocompromised adults - the suppression of recurrent genital herpes in immunocompetent and immunocompromisedadults clinical studies have not been conducted in hsv-infected patients immunocompromised for other causes than hiv-infection

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - famciclovir, quantity: 500 mg - tablet - excipient ingredients: titanium dioxide; poloxamer; stearic acid; macrogol 8000; hypromellose - famciclovir is indicated for:,= treatment of herpes zoster infection in adult patients who commence therapy within 72 hours of the onset of rash. greatest benefit occurs if the drug is started within 48 hours. efficacy has not been demonstrated in patients less than 50 years of age, although the occasional younger patient with severe herpes zoster may benefit from therapy with famciclovir. herpes zoster infection is generally a milder condition in younger patients.,= treatment of recurrent episodes of genital herpes in adults and adolescents 12 years of age and older.,= suppression of recurrent genital herpes.,= treatment of recurrent herpes labialis (cold sores) in immunocompetent adult patients.,famciclovir is also indicated in immunocompromised patients for:,= treatment of uncomplicated herpes zoster,= treatment of recurrent herpes simplex,= suppression of recurrent herpes simplex.

Australia - English - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - famciclovir, quantity: 500 mg - tablet, film coated - excipient ingredients: sodium starch glycollate; hyprolose; purified water; microcrystalline cellulose; silicon dioxide; magnesium stearate; titanium dioxide; lactose monohydrate; hypromellose; macrogol 4000 - for the treatment of recurrent herpes labialis (cold sores) in immunocompetent adult patients aged 18 years and over.

Malta - English - Medicines Authority

actavis group ptc ehf revkjavikurvegi 76-78, 220 hafnarfjordur, iceland - famciclovir - film-coated tablet - famciclovir 125 mg - antivirals for systemic use

Malta - English - Medicines Authority

actavis group ptc ehf revkjavikurvegi 76-78, 220 hafnarfjordur, iceland - famciclovir - film-coated tablet - famciclovir 250 mg - antivirals for systemic use

Malta - English - Medicines Authority

actavis group ptc ehf revkjavikurvegi 76-78, 220 hafnarfjordur, iceland - famciclovir - film-coated tablet - famciclovir 500 mg - antivirals for systemic use